Anti - Viral

Acyclor Cream 5% w/w

Aciclovir

Strength
5 % w/w
Dosage form
Cream
Pack size
5 g
Packing
Tube
Acyclor Cream 5% w/w

Product information

QUANTITATIVE COMPOSITION

Each gram of cream contains 50 mg of Aciclovir (equivalent to 5% w/w).
Dosage Form: Cream (Topical)

CLINICAL PARTICULARS

Therapeutic Indications

Topical Treatment of:

  • Recurrent herpes simplex labialis (cold sores) caused by herpes simplex virus type 1 or 2.

Posology and method of administration

Posology:

  • Apply a thin layer of cream to the affected area 5 times daily (approximately every 4 hours while awake) for 4 days.
  • Treatment should be initiated as soon as the first symptoms of a herpes episode appear (e.g., tingling, redness, itching).

Special Populations:

  • Pediatric Population: Safety and efficacy established in children ≥12 years. Not recommended for children <12 years.
  • Elderly: No dose adjustment necessary.
  • Renal/Hepatic Impairment: Not applicable due to minimal systemic absorption.

Method of Administration:

  • For topical use only. Avoid contact with eyes and mucous membranes.
  • Wash hands before and after application.

 

Contraindications

  • Hypersensitivity to aciclovir, valaciclovir, or any of the excipients.
  • Application on mucous membranes or open wounds.

 

Special warnings and precautions for use

  • Not for ophthalmic use.
  • If lesions do not improve after 10 days of treatment or worsen, seek medical advice.
  • Use with caution in patients with severely impaired immune systems.
  • Avoid extensive application to large areas of damaged skin.

 

Interaction with other medicinal products and other forms of interaction

  • Due to minimal systemic absorption, no significant drug interactions are expected.
Fertility, Pregnancy and Lactation
  • Pregnancy: Limited data available; use only if clearly needed and benefit outweighs risk.
  • Lactation: Unknown if aciclovir is excreted in breast milk following topical use; caution advised.

 

Effects on ability to drive and use machines

  • No effect expected.
Undesirable Effects

Frequency Categories (CIOMS III):

Very common (≥1/10)

Common (≥1/100 to <1/10)

Uncommon (≥1/1,000 to <1/100)

Rare (<1/1,000)

      -

Local skin reactions such as mild burning, itching, redness

Allergic dermatitis, rash

Severe hypersensitivity reactions (very rare)

  • Usually mild and transient; discontinue if severe irritation occurs.
Overdose
  • Topical overdose is unlikely to cause systemic toxicity.
  • In case of accidental ingestion, provide symptomatic treatment.
PHARMACOLOGICAL PROPERTIES

Pharmacodynamic Properties

  • Aciclovir is a synthetic purine nucleoside analogue active against herpes viruses.
  • It selectively inhibits viral DNA polymerase after conversion to aciclovir triphosphate in virus-infected cells, resulting in inhibition of viral DNA replication.

Pharmacokinetic Properties

  • Minimal systemic absorption after topical application.
  • Metabolism and elimination follow systemic aciclovir pathways if absorbed.

 

 

Special precautions for storage

  • Store below 25°C.
  • Do not freeze.